Literature DB >> 16735926

Not all SERMs are created equal.

Steven R Goldstein.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16735926     DOI： 10.1097/01.gme.0000222332.31101.42

Source DB:  PubMed          Journal:  Menopause        ISSN： 1072-3714            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Lasofoxifene: Evidence of its therapeutic value in osteoporosis.

Authors:  Luigi Gennari; Daniela Merlotti; Vincenzo De Paola; Ranuccio Nuti
Journal:  Core Evid       Date:  2010-06-15

Review 2.  The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice.

Authors:  Philipp Y Maximov; Theresa M Lee; V Craig Jordan
Journal:  Curr Clin Pharmacol       Date:  2013-05

3.  Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy.

Authors:  S R Goldstein; G A Bachmann; P R Koninckx; V H Lin; D J Portman; O Ylikorkala
Journal:  Climacteric       Date:  2013-11-23       Impact factor: 3.005

Review 4.  Selective estrogen receptor modulators: tissue specificity and clinical utility.

Authors:  Stephen Martinkovich; Darshan Shah; Sonia Lobo Planey; John A Arnott
Journal:  Clin Interv Aging       Date:  2014-08-28       Impact factor: 4.458
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.